FINHUB Insights

MCK · Q1 FY27 · Apr 1 – Jun 30, 2026

McKesson Q1 FY27: where the revenue came from and where it went

McKesson Q1 FY27: revenue $105.4B (+8% year over year). Net profit $0.6B. Largest cohort North american $86.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Aug 5, 2026 10-Q
Sankey diagram of McKesson's income statement for Q1 FY27: revenue of $105.38 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$105.38B +8% year over year
Gross profit$3.69B 3% margin
Operating profit$1.32B 1% margin
Net profit$0.61B 1% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY27 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 105.38 100% +8%
North american 86.77 82%
Oncology & multispecialty 14.22 13%
Medical-Surgical 2.82 3%
Prescription technology 1.57 1%
Cost of revenue−101.7097%
Gross profit3.693% margin+0pp
SG&A−2.262%+0pp
Other−0.100%+0pp
Operating profit1.321% margin+0pp
Tax−0.28
Interest & other costs−0.43
Net profit0.611%+0pp
Filing on EDGAR More quarters of MCK

Source of the numbers: tables in the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.